BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34321328)

  • 1. KDM3A regulates alternative splicing of cell-cycle genes following DNA damage.
    Baker M; Petasny M; Taqatqa N; Bentata M; Kay G; Engal E; Nevo Y; Siam A; Dahan S; Salton M
    RNA; 2021 Nov; 27(11):1353-1362. PubMed ID: 34321328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
    Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
    Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
    Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
    Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
    Cho HS; Toyokawa G; Daigo Y; Hayami S; Masuda K; Ikawa N; Yamane Y; Maejima K; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
    Int J Cancer; 2012 Aug; 131(3):E179-89. PubMed ID: 22020899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
    Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T
    Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature.
    Gonzalez I; Munita R; Agirre E; Dittmer TA; Gysling K; Misteli T; Luco RF
    Nat Struct Mol Biol; 2015 May; 22(5):370-6. PubMed ID: 25849144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase KDM3A is required for enhancer activation of hippo target genes in colorectal cancer.
    Wang HY; Long QY; Tang SB; Xiao Q; Gao C; Zhao QY; Li QL; Ye M; Zhang L; Li LY; Wu M
    Nucleic Acids Res; 2019 Mar; 47(5):2349-2364. PubMed ID: 30649550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Nakatsuka T; Tateishi K; Kudo Y; Yamamoto K; Nakagawa H; Fujiwara H; Takahashi R; Miyabayashi K; Asaoka Y; Tanaka Y; Ijichi H; Hirata Y; Otsuka M; Kato M; Sakai J; Tachibana M; Aburatani H; Shinkai Y; Koike K
    Oncogene; 2017 Nov; 36(45):6262-6271. PubMed ID: 28692045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
    Ajiro M; Tang S; Doorbar J; Zheng ZM
    J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
    Wade MA; Jones D; Wilson L; Stockley J; Coffey K; Robson CN; Gaughan L
    Nucleic Acids Res; 2015 Jan; 43(1):196-207. PubMed ID: 25488809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF5 regulates alternative splicing of
    Li J; Li G; Qi Y; Lu Y; Wang H; Shi K; Li D; Shi J; Stovall DB; Sui G
    RNA Biol; 2021 Oct; 18(sup1):318-336. PubMed ID: 34291726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific phosphorylation of histone demethylase KDM3A determines target gene expression in response to heat shock.
    Cheng MB; Zhang Y; Cao CY; Zhang WL; Zhang Y; Shen YF
    PLoS Biol; 2014 Dec; 12(12):e1002026. PubMed ID: 25535969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
    Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.
    Tripathi V; Ellis JD; Shen Z; Song DY; Pan Q; Watt AT; Freier SM; Bennett CF; Sharma A; Bubulya PA; Blencowe BJ; Prasanth SG; Prasanth KV
    Mol Cell; 2010 Sep; 39(6):925-38. PubMed ID: 20797886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage.
    Cloutier A; Shkreta L; Toutant J; Durand M; Thibault P; Chabot B
    Sci Rep; 2018 Feb; 8(1):2206. PubMed ID: 29396485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
    Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
    J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.